| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6064651 | Journal of Allergy and Clinical Immunology | 2014 | 13 Pages |
Abstract
COX inhibition abrogated immune tolerance by suppressing PGI2 IP signaling, suggesting that PGI2 signaling promotes immune tolerance and that clinical use of COX-inhibiting drugs may increase the risk of developing allergic diseases.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Weisong PhD, Kasia MS, Jian MS, Daniel E. MD, Shinji PhD, Matthew T. BS, Dawn C. PhD, Madison G. BS, Vasiliy V. MD, PhD, Ginger L. PhD, Pingsheng PhD, Martin L. PhD, Garret A. MD, FRS, R. Stokes MD,